Pharma’s launch leaders are among the most capable professionals in the industry, yet, even their best efforts often fall short. Nearly 60% of new product launches miss expectations, not because the science fails, but because market execution has not kept pace with the speed and complexity of today’s data environment.1 The result is missed opportunities, delayed access, and unrealised value.